Mostrando entradas con la etiqueta Pulp Therapy. Mostrar todas las entradas
Mostrando entradas con la etiqueta Pulp Therapy. Mostrar todas las entradas

miércoles, 11 de noviembre de 2026

Pulpal Necrosis: When Are Antibiotics Necessary?

pulpal necrosis

Pulpal necrosis is characterized by the death of the dental pulp, generally following an inflammatory process, trauma, or microbial invasion. Once the pulp becomes necrotic, microorganisms may colonize the root canal system and contribute to the development of apical periodontitis, periapical abscesses, and, in more advanced cases, spreading odontogenic infections.

📌 Recommended Article :
Dental Article 🔽 Triple Antibiotic Paste (TAP) in Pediatric Endodontics: Current Clinical Evidence ... Triple Antibiotic Paste (TAP) has gained significant attention in pediatric endodontics, particularly in the management of necrotic primary teeth and immature permanent teeth.
However, pulpal necrosis does not automatically require systemic antibiotic therapy. Most localized endodontic infections in immunocompetent patients can be managed through appropriate dental intervention, including root canal treatment and abscess drainage.

Advertisement

The pharmacological approach should be based on the clinical presentation, severity of infection, systemic manifestations, and availability of definitive dental treatment.
Antibiotics are reserved for selected clinical situations, whereas analgesics and anti-inflammatory medications help control associated pain.

📌 Recommended Article :
Dental Article 🔽 Pulp Necrosis in Primary Teeth: Diagnosis and Evidence-Based Management ... Early detection is crucial to prevent infection, pathological root resorption, and damage to the developing permanent successor.
✅ Clinical Conditions Associated with Pulpal Necrosis
The distinction between localized and spreading infection is essential when deciding whether systemic antibiotics are necessary.
Clinical condition Main manifestations Antibiotic indication
Pulp necrosis with symptomatic apical periodontitis Pain on percussion or biting, without swelling or systemic manifestations Not routinely indicated
Localized acute apical abscess Localized swelling, purulent collection and tenderness Depends on availability of immediate definitive dental treatment
Acute apical abscess with systemic involvement Fever, malaise, lymphadenopathy or systemic manifestations Indicated
Spreading odontogenic infection Cellulitis, progressive facial swelling, trismus or fascial space involvement Indicated, with urgent specialist assessment
Clinical principle: The presence of pain, pulp necrosis, or localized periapical inflammation alone does not justify systemic antibiotic prescribing.

📌 Recommended Article :
Dental Article 🔽 CTZ Paste in Primary Teeth Pulp Therapy: Indications, Benefits and Clinical Protocol ... The use of CTZ paste (Chloramphenicol–Tetracycline–Zinc Oxide) in primary teeth remains a topic of interest, especially in cases of infected primary molars where traditional pulpectomy is not feasible.
✅ When Are Antibiotics Necessary?
According to the American Dental Association (ADA) guideline, antibiotic prescribing depends on the diagnosis and whether definitive conservative dental treatment (DCDT) is immediately available.

1. Conditions That Generally Do Not Require Antibiotics
▪️ Pulp necrosis with symptomatic apical periodontitis: Root canal treatment is indicated; systemic antibiotics are not routinely recommended.
▪️ Localized acute apical abscess when immediate dental treatment is available: Drainage and definitive endodontic treatment are preferred over adjunctive antibiotics in immunocompetent adults.

2. Conditions That May Require Antibiotics
▪️ Localized acute apical abscess when immediate definitive dental treatment is unavailable: The ADA suggests antibiotic therapy alongside urgent referral for definitive treatment.
▪️ Acute apical abscess with systemic involvement: Antibiotics are recommended in conjunction with urgent source control.
▪️ Progressive odontogenic infection: Cellulitis, rapidly spreading swelling, or involvement of deeper anatomical spaces requires systemic treatment and urgent assessment.

The ADA recommendations primarily address immunocompetent adults. Patients with significant immunosuppression or other medical risk factors require individualized assessment.

📌 Recommended Article :
Dental Article 🔽 Dexamethasone in Endodontics: Benefits Beyond Injections ... Intracanal dexamethasone is an emerging topic of interest in endodontics because of its potential to modulate inflammation and reduce post-instrumentation pain.
✅ Antibiotic Selection and Recommended Regimens
When antibiotic therapy is indicated, amoxicillin is the preferred first-line option for most immunocompetent adults without penicillin allergy.

1. First-Line Antibiotics
Antibiotic Adult dosage Duration
Amoxicillin 500 mg every 8 hours 3–7 days
Penicillin V potassium 500 mg every 6 hours 3–7 days
Amoxicillin is generally preferred because of its activity against relevant odontogenic microorganisms, including several gram-negative anaerobes, and its favorable gastrointestinal tolerability.

2. Alternatives for Penicillin Allergy
The alternative should be selected according to the type of allergic reaction and the patient's medical history.
Antibiotic Adult dosage Clinical considerations
Cephalexin 500 mg every 6 hours Consider when there is no history of anaphylaxis, angioedema, or urticaria associated with penicillin.
Azithromycin 500 mg on day 1, followed by 250 mg daily on days 2–5 Alternative in selected patients with immediate-type penicillin allergy.
Clindamycin is generally not preferred because of its association with Clostridioides difficile infection, including severe and potentially life-threatening cases. Its use should be avoided when safer effective alternatives are available.

3. Antibiotic Escalation in Treatment Failure
When the patient shows inadequate clinical improvement or progressive infection despite initial therapy, reassessment is essential.

For patients without penicillin allergy, the ADA guideline describes two possible approaches:
▪️ Metronidazole: 500 mg every 8 hours for 7 days, added to the initial antibiotic.
▪️ Amoxicillin/clavulanate: 500/125 mg every 8 hours for 7 days, replacing the initial antibiotic.

These regimens are not routine first-line treatments. Before escalating antibiotic therapy, clinicians should evaluate whether drainage and definitive source control have been adequately achieved.
Follow-up: Reassess the patient within 3 days. Antibiotics should be discontinued 24 hours after complete resolution of symptoms, according to the ADA guideline.

📌 Recommended Article :
Dental Article 🔽 Empirical Antibiotic Therapy in Dentistry: A Practical Guide ... Empirical antibiotic therapy in dentistry means prescribing an antibiotic before laboratory culture or susceptibility test results are available.
✅ Pharmacological Management of Dental Pain
Although antibiotics address selected bacterial infections, they are not analgesics and should not be prescribed solely to relieve endodontic pain.
Nonsteroidal anti-inflammatory drugs (NSAIDs), alone or combined with acetaminophen, are preferred for temporary management of acute dental pain.
Medication Suggested adult dosage Main indication
Ibuprofen 400 mg every 6–8 hours, as needed First-line analgesic and anti-inflammatory
Naproxen sodium 440 mg initially, followed by 220 mg every 8–12 hours Alternative NSAID
Acetaminophen 500–1,000 mg every 6–8 hours, as needed Alternative or adjunctive analgesic
Clinical Considerations
▪️ Ibuprofen plus acetaminophen may provide greater analgesia than either medication alone.
▪️ NSAIDs require caution or avoidance in patients with active peptic ulcer disease, significant renal impairment, certain cardiovascular conditions, or relevant anticoagulant use.
▪️ Acetaminophen requires dose adjustment or avoidance in certain patients with hepatic disease or substantial alcohol consumption.
▪️ Opioids are not recommended as routine first-line therapy for acute dental pain.

The 2024 ADA guideline supports NSAIDs, alone or in combination with acetaminophen, as preferred pharmacological options for acute dental pain.

📌 Recommended Article :
Dental Article 🔽 Pulp Exposure in Children: Emergency Treatment Guide ... Pulp exposure in children is a time-sensitive clinical finding that may occur during deep caries removal, restorative procedures, or dental trauma.
✅ Definitive Treatment: Control of the Infectious Source
Definitive dental treatment is the cornerstone of managing pulpal necrosis and its infectious complications. Pharmacological therapy cannot reliably eliminate infection while the necrotic root canal system or undrained abscess remains untreated.

The principal interventions include:
▪️ Nonsurgical root canal treatment: Removal of necrotic pulp tissue, chemomechanical preparation, irrigation, disinfection, and subsequent obturation.
▪️ Incision and drainage: Indicated when a localized, accessible fluctuant abscess is present.
▪️ Tooth extraction: Appropriate when the tooth has a poor restorative or endodontic prognosis.

Emergency Referral Criteria
The following findings suggest potentially serious infection and require urgent evaluation:
▪️ Rapidly progressive facial or cervical swelling.
▪️ Significant trismus.
▪️ Dysphagia or difficulty swallowing.
▪️ Floor-of-mouth elevation.
▪️ Dyspnea or signs of airway compromise.
▪️ Systemic toxicity or deterioration of general condition.

Suspected deep fascial space infection or airway compromise requires emergency hospital assessment, not outpatient antibiotic treatment alone.
The European Society of Endodontology (ESE) S3 guideline emphasizes definitive endodontic treatment and restricts systemic antibiotics to selected circumstances, including systemic involvement, progressive infections, and certain medically compromised patients.

📌 Recommended Article :
Dental Article 🔽 CTZ Paste in Pediatric Dentistry: Indications, Composition, and Success Rates ... This technique, often referred to as non-instrumentation endodontic treatment (NIET), has gained attention due to its simplicity, reduced chair time, and favorable outcomes in young or uncooperative children.
💬 Clinical Discussion
The management of pulpal necrosis requires a clear distinction between infection confined to the root canal and infection that has extended into periapical or surrounding tissues. This distinction determines whether systemic pharmacological treatment is necessary.
The ADA guideline by Lockhart et al. (2019) recommends against routine antibiotic prescribing for most pulpal and periapical conditions in immunocompetent adults. However, it recognizes specific circumstances in which antibiotics may be appropriate, particularly acute apical abscesses with systemic involvement and localized abscesses when immediate definitive treatment is unavailable.
The ESE S3 guideline (2023) reinforces the importance of endodontic source control, while the ADA guideline published in 2024 supports non-opioid medications for acute dental pain.
An important clinical consideration is that antibiotic selection should never substitute for reassessment of the infectious source. Persistent symptoms may indicate inadequate drainage, untreated canal anatomy, progression into deeper spaces, or an incorrect diagnosis rather than simply insufficient antibiotic coverage.
Therefore, appropriate prescribing requires integration of clinical diagnosis, definitive dental treatment, analgesic management, and antimicrobial stewardship.

✍️ Conclusion
Systemic antibiotics are not routinely necessary for pulpal necrosis. Their use should be restricted to selected cases involving systemic manifestations, progressive infection, or circumstances in which a localized acute apical abscess cannot receive immediate definitive dental treatment.
Amoxicillin and penicillin V are the principal first-line options when antibiotics are indicated in immunocompetent adults. NSAIDs, with or without acetaminophen, remain the preferred pharmacological approach to acute dental pain.
Ultimately, definitive endodontic treatment and adequate drainage are more important than antibiotic prescription alone for controlling the infectious source and preventing complications.

🎯 Clinical Recommendations
1. Avoid unnecessary antibiotic prescriptions: Pulpal necrosis and symptomatic apical periodontitis without swelling or systemic involvement generally do not require antibiotics.
2. Prioritize source control: Perform root canal treatment, drainage, or extraction according to the diagnosis and prognosis.
3. Evaluate systemic involvement: Fever, malaise, lymphadenopathy, progressive swelling, and fascial space involvement require careful assessment for systemic antibiotic therapy.
4. Reassess treatment response: Patients receiving antibiotics should be evaluated within 3 days to determine whether infection is resolving or requires further intervention.
5. Practice antimicrobial stewardship: Select the narrowest appropriate antibiotic, use the recommended duration, and avoid unnecessary combinations or prolonged prescriptions.

📚 References
✔ Lockhart, P. B., Tampi, M. P., Abt, E., Aminoshariae, A., Durkin, M. J., Fouad, A. F., Gopal, P., Hatten, B. W., Kennedy, E., Lang, M. S., Patton, L. L., Paumier, T., Suda, K. J., Pilcher, L., Urquhart, O., O'Brien, K. K., & Carrasco-Labra, A. (2019). Evidence-based clinical practice guideline on antibiotic use for the urgent management of pulpal- and periapical-related dental pain and intra-oral swelling. The Journal of the American Dental Association, 150(11), 906–921.e12. https://doi.org/10.1016/j.adaj.2019.08.020
✔ Duncan, H. F., et al. (2023). Treatment of pulpal and apical disease: The European Society of Endodontology (ESE) S3-level clinical practice guideline. International Endodontic Journal, 56(Suppl. 3), 238–295. https://doi.org/10.1111/iej.13974
✔ Carrasco-Labra, A., Polk, D. E., Urquhart, O., Aghaloo, T., Claytor, J. W., Jr., Dhar, V., Dionne, R. A., Espinoza, L., Gordon, S. M., Hersh, E. V., Law, A. S., Li, B. S.-K., Schwartz, P. J., Suda, K. J., Turturro, M. A., Wright, M. L., Dawson, T., Miroshnychenko, A., Pahlke, S., ... Moore, P. A. (2024). Evidence-based clinical practice guideline for the pharmacologic management of acute dental pain in adolescents, adults, and older adults. The Journal of the American Dental Association, 155(2), 102–117.e9. https://doi.org/10.1016/j.adaj.2023.10.009

📌 More Recommended Items

► Pulpotomy vs. Pulpectomy in Primary Teeth: A Contemporary Clinical Guide
► Why Pulp Therapy Fails: Risk Factors, Clinical Errors, and Evidence-Based Solutions
► Limitations of CTZ and Antibiotic Pastes in Pediatric Endodontics: Resistance, Tooth Discoloration, and Safety Concerns

domingo, 8 de noviembre de 2026

Intracanal and Systemic Dexamethasone in Endodontics: Indications & Evidence

dexamethasone - endodontics

Dexamethasone in endodontics has been investigated as an adjunctive anti-inflammatory agent for reducing postoperative pain associated with root canal treatment.

📌 Recommended Article :
Dental Article 🔽 Zinc Oxide Eugenol vs Calcium Hydroxide–Iodoform in Pulpectomy ... Pulpectomy in primary teeth requires obturation materials that ensure antimicrobial efficacy, biocompatibility, and physiological resorption.
Its primary therapeutic effect is the suppression of inflammatory mediators involved in periapical inflammation and nociceptive sensitization.

Advertisement

Two main approaches have been explored: local administration, including intracanal application and corticosteroid-containing irrigation protocols, and systemic administration, particularly oral and injectable routes.
Although clinical studies suggest that dexamethasone can reduce postoperative pain, its effectiveness depends on the administration route, clinical indication, and patient characteristics.
It is important to distinguish its analgesic role from definitive endodontic treatment: corticosteroids do not eliminate microorganisms or replace adequate chemomechanical preparation and disinfection.

📌 Recommended Article :
Dental Article 🔽 CTZ Paste in Pediatric Dentistry: Indications, Composition, and Success Rates ... This technique, often referred to as non-instrumentation endodontic treatment (NIET), has gained attention due to its simplicity, reduced chair time, and favorable outcomes in young or uncooperative children.
✅ Mechanism of Action
Dexamethasone is a potent synthetic glucocorticoid that reduces inflammation through several mechanisms:

▪️ Phospholipase A2 inhibition: Reduces the production of prostaglandins and leukotrienes by inhibiting arachidonic acid release.
▪️ Cytokine suppression: Decreases the expression of pro-inflammatory mediators, including IL-1, IL-6, and TNF-α.
▪️ Reduced vascular permeability: Limits inflammatory edema and tissue swelling.
▪️ Modulation of nociception: Reduces peripheral inflammatory sensitization, contributing to postoperative pain relief.

These effects may be particularly relevant in teeth with symptomatic irreversible pulpitis, symptomatic apical periodontitis, and postoperative inflammatory pain.

📌 Recommended Article :
Dental Article 🔽 Dexamethasone in Endodontics: Benefits Beyond Injections ... Dexamethasone is a potent glucocorticoid that suppresses inflammatory mediator production and modulates the host inflammatory response.
✅ Intracanal Dexamethasone: Indications and Clinical Evidence
Intracanal dexamethasone has been investigated as a local approach to reduce inflammatory responses following root canal instrumentation.
Its application has primarily been studied as a final intracanal rinse rather than as a conventional long-term intracanal medicament.

Main applications
▪️ Final intracanal irrigation: Administration after chemomechanical preparation to reduce postoperative inflammatory pain.
▪️ Symptomatic irreversible pulpitis: An adjunctive approach in patients at increased risk of postoperative discomfort.
▪️ Post-instrumentation inflammation: Potential reduction of inflammatory responses associated with mechanical and chemical irritation of periapical tissues.

Scientific evidence
A randomized clinical trial involving 60 patients with symptomatic irreversible pulpitis evaluated dexamethasone (4 mg/mL) as a final intracanal rinse. The reported effectiveness in relieving postoperative pain was 86.67%, compared with 20% in the saline control group.
Other clinical investigations have also evaluated dexamethasone solutions as final irrigants, reporting reductions in postoperative pain. However, differences in protocols, sample sizes, and outcome measurements limit the generalizability of these findings.

Important distinction: Intracanal dexamethasone irrigation should not be confused with placing corticosteroid preparations inside the canal as an interappointment dressing. Evidence supporting routine use of dexamethasone as a standalone intracanal medicament remains insufficient.

📌 Recommended Article :
Dental Article 🔽 Why Hydrogen Peroxide Should Not Be Used in Modern Endodontic Treatment: Evidence-Based Clinical Justification ... This article explains why hydrogen peroxide is no longer recommended in endodontic treatments, supported by contemporary scientific evidence.
✅ Systemic Dexamethasone: Indications and Clinical Evidence
Systemic dexamethasone has a more extensive clinical evidence base than direct intracanal application, particularly for reducing postoperative endodontic pain.

It has been administered through different routes:
▪️ Oral administration: Preoperative or perioperative administration.
▪️ Intramuscular injection: Used in selected clinical protocols.
▪️ Supraperiosteal or intraligamentary injection: Local injection with systemic corticosteroid activity, investigated for preemptive pain control.

Clinical indications
Systemic administration may be considered in selected patients presenting with:
▪️ Symptomatic irreversible pulpitis with significant preoperative pain.
▪️ Increased risk of postoperative inflammatory pain.
▪️ Anticipated postoperative discomfort following endodontic procedures.
▪️ Situations in which conventional analgesic management requires an individualized adjunctive approach.

Evidence from systematic reviews
A 2024 systematic review and meta-analysis by Alajlan et al. included 29 clinical trials involving 2,303 participants.

The results demonstrated that corticosteroid administration reduced the likelihood of postoperative pain at:
▪️ 6 hours: RR = 2.50.
▪️ 12 hours: RR = 2.10.
▪️ 24 hours: RR = 1.77.

The authors rated the certainty of evidence as moderate, supporting a clinically relevant reduction in postoperative endodontic pain. These findings concern systemic and locally injected corticosteroids collectively, not dexamethasone exclusively.
A further systematic review published in 2026 evaluated nine randomized clinical trials involving 917 participants. It found that preemptive corticosteroid injections, particularly dexamethasone administered through infiltrative routes, reduced postoperative pain, with the greatest effects during the first 24 hours.

📌 Recommended Article :
Dental Article 🔽 Triple Antibiotic Paste (TAP) in Pediatric Endodontics: Current Clinical Evidence ... Triple Antibiotic Paste (TAP) has gained significant attention in pediatric endodontics, particularly in the management of necrotic primary teeth and immature permanent teeth.
✅ Intracanal vs. Systemic Dexamethasone
The two approaches differ in their administration, intended distribution, and strength of supporting evidence.
Parameter Intracanal Dexamethasone Systemic Dexamethasone
Administration Final canal rinse or local application Oral or injectable
Main objective Local inflammatory modulation Systemic anti-inflammatory effect
Primary application Post-instrumentation pain reduction Preemptive or postoperative pain control
Evidence Limited clinical trials Systematic reviews and meta-analyses
Systemic exposure Expected to be lower, but not necessarily absent Expected and clinically relevant
Routine use Not established Not routinely indicated for every case
✅ Dosage Considerations and Safety
There is no universally established dexamethasone protocol for endodontic treatment. Published clinical trials have investigated different doses, administration routes, and timing.
For example, a 2026 randomized clinical trial evaluated 4 mg oral dexamethasone administered one hour before treatment in 82 patients. The dexamethasone group showed lower postoperative pain scores than the ibuprofen comparison group between 6 and 24 hours. Nevertheless, the limited sample size and single-center design warrant further validation.

Clinical precautions
Before prescribing systemic dexamethasone, clinicians should assess:
▪️ History of hypersensitivity to corticosteroids. ▪️ Uncontrolled diabetes mellitus. ▪️ Active or untreated infections. ▪️ Peptic ulcer disease and relevant gastrointestinal risks. ▪️ Immunosuppression and other conditions potentially aggravated by corticosteroids. ▪️ Pregnancy, lactation, and concomitant medication use.

Potential adverse effects include transient hyperglycemia, gastrointestinal disturbances, sleep disturbances, mood changes, and immunosuppressive effects.
Short-term administration generally presents fewer risks than prolonged corticosteroid exposure, but it is not risk-free.
Intracanal administration also requires caution. The solution must not compromise the effectiveness of canal disinfection, and extrusion beyond the apical foramen should be avoided.

📌 Recommended Article :
Dental Article 🔽 Zinc Oxide–Eugenol Paste in Modern Dentistry: Current Uses, Benefits, and Limitations ... Despite the emergence of bioactive and resin-based alternatives, ZOE continues to play a role in specific clinical situations due to its sedative, antimicrobial, and sealing properties.
💬 Discussion
The available evidence supports dexamethasone as a potentially useful adjunct for controlling postoperative endodontic pain, particularly during the first 24 hours.
However, the evidence is not equally strong for both administration routes. Systemic corticosteroids have been evaluated in a substantially larger number of clinical trials, whereas intracanal application remains supported by fewer studies and less standardized protocols.
An important consideration is that pain reduction does not necessarily indicate improved periapical healing or long-term endodontic success. Corticosteroids suppress inflammation but do not provide antimicrobial activity.
Furthermore, the clinical benefit must be balanced against patient-specific contraindications and the availability of conventional analgesic strategies.
Future randomized clinical trials should directly compare intracanal and systemic dexamethasone, establish optimal administration protocols, and evaluate both short-term pain control and longer-term clinical outcomes.

🎯 Clinical Recommendations
Based on the available evidence, the following recommendations are appropriate for clinical practice:
1. Prioritize definitive endodontic treatment: Adequate instrumentation, irrigation, working-length control, and apical debridement remain fundamental to controlling endodontic inflammation.
2. Consider systemic dexamethasone selectively: It may be considered as an adjunct in carefully selected patients with significant inflammatory pain, following medical history assessment and contraindication screening.
3. Use intracanal dexamethasone cautiously: Its use as a final rinse remains promising, but insufficient evidence supports its routine incorporation into standard irrigation protocols.
4. Avoid substituting corticosteroids for analgesics or disinfection: Dexamethasone should not replace appropriate analgesic therapy, antimicrobial procedures, or drainage when clinically indicated.
5. Reassess persistent symptoms: Increasing pain, swelling, or systemic manifestations require evaluation for persistent infection, inadequate drainage, or other treatment-related complications.

✍️ Conclusion
Dexamethasone in endodontics represents a potentially valuable adjunct for managing postoperative inflammatory pain. Systemic administration has stronger supporting evidence, with systematic reviews demonstrating significant pain reduction during the first 24 hours after treatment.
Intracanal administration, particularly as a final irrigation solution, has also demonstrated promising results, although its clinical evidence remains limited.
Ultimately, dexamethasone should be used selectively and as an adjunct to evidence-based endodontic treatment, rather than as a substitute for adequate canal disinfection and conventional pain management.

📚 References
✔ Alajlan, N., Carrasco-Labra, A., Karabucak, B., & Lee, S. M. (2024). Systemic corticosteroid uses in endodontics—Part 1: Managing postoperative pain. Journal of Endodontics, 50(6), 724–734. https://doi.org/10.1016/j.joen.2024.03.004
✔ Dildar, I., Moghal, A., Mirza, A., Zaheer, M. A., Mallick, M. R., & Munir, S. (2024). Evaluation of postoperative pain after using dexamethasone intracanal rinse in irreversible pulpitis. Journal of the College of Physicians and Surgeons Pakistan, 34(4), 390–393. https://doi.org/10.29271/jcpsp.2024.04.390
✔ Nogueira, B. M. L., Silva, L. G., Mesquita, C. R. M., Menezes, S. A. F., Menezes, T. O. A., Faria, A. G. M., & Porpino, M. T. M. (2018). Is the use of dexamethasone effective in controlling pain associated with symptomatic irreversible pulpitis? A systematic review. Journal of Endodontics, 44(5), 703–710. https://doi.org/10.1016/j.joen.2018.02.006
✔ Nath, R., Daneshmand, A., Sizemore, D., Guo, J., & Enciso, R. (2018). Efficacy of corticosteroids for postoperative endodontic pain: A systematic review and meta-analysis. Journal of Dental Anesthesia and Pain Medicine, 18(4), 205–221. https://doi.org/10.17245/jdapm.2018.18.4.205
✔ Al-Yamoor, R., Stefanescu, S. V., Iuga, M. M., Espada-Salgado, F. M., Bilsborrow, S., Teja, K. V., & Vasundhara, K. A. (2026). Effect of pre-emptive injection-based corticosteroid administration and its routes on post-endodontic pain: A systematic review and meta-analysis of randomized clinical trials. Journal of Clinical and Experimental Dentistry, 18(5), e688–e703. https://doi.org/10.4317/jced.64027
✔ Nils, H. J., Arce Recatalá, C., Galletti, C., & Flores-Fraile, J. (2026). Therapeutic management of dexamethasone in patients undergoing endodontics: A randomized clinical trial. Odontology, 114(4), 2158–2169. https://doi.org/10.1007/s10266-025-01277-0

📌 More Recommended Items

► Why Is Dental Pain More Intense at Night?
► Pulp Necrosis in Primary Teeth: Diagnosis and Evidence-Based Management
► CTZ Paste in Primary Teeth Pulp Therapy: Indications, Benefits and Clinical Protocol

jueves, 22 de octubre de 2026

Dexamethasone in Endodontics: Benefits Beyond Injections.

dexamethasone - endodontics

Intracanal dexamethasone is an emerging topic of interest in endodontics because of its potential to modulate inflammation and reduce post-instrumentation pain.

📌 Recommended Article :
Dental Article🔽 Updated Dexamethasone Management in Dentistry: Pharmacology, Clinical Applications, and Protocols ... This article reviews pharmacokinetics, pharmacodynamics, clinical indications, drug combinations, limitations, and updated evidence-based protocols.
Unlike systemic corticosteroid therapy, local application aims to deliver an anti-inflammatory agent directly into the root canal system.

Advertisement

Dexamethasone has been investigated as an intracanal solution and as a component of calcium hydroxide-based medicaments. Related corticosteroid-containing pastes also provide a clinical context for understanding the potential benefits and limitations of local anti-inflammatory therapy.
However, these formulations are not interchangeable, and evidence supporting one preparation cannot automatically be extrapolated to another.

📌 Recommended Article :
Dental Article🔽 Zinc Oxide Eugenol vs Calcium Hydroxide–Iodoform in Pulpectomy ... The ideal obturation material should exhibit resorbability synchronized with root resorption, antimicrobial properties, and minimal toxicity to periapical tissues.
✅ Why Use Dexamethasone as an Intracanal Medicament?
Dexamethasone is a potent glucocorticoid that suppresses inflammatory mediator production and modulates the host inflammatory response.

In endodontics, its proposed benefits include:
▪️ Reduction of postoperative pain associated with periapical inflammation.
▪️ Modulation of inflammatory responses following instrumentation.
▪️ Potential improvement in patient comfort during interappointment periods.

Importantly, dexamethasone is not an antimicrobial substitute for sodium hypochlorite irrigation, adequate chemomechanical preparation, or other established infection-control procedures.

📌 Recommended Article :
Dental Article🔽 Dexamethasone Side Effects in Dentistry: Clinical Risks Guide ... However, clinicians must be aware of its potential adverse effects, contraindications, and systemic implications, even when administered as a single dose.
✅ Intracanal Dexamethasone: Solutions and Paste Formulations
Two approaches deserve particular attention: direct intracanal application of a corticosteroid solution and incorporation of dexamethasone into an intracanal paste.
Formulation Potential Purpose Main Limitation
Intracanal dexamethasone solution Potential local anti-inflammatory action and postoperative pain control. Limited clinical evidence and variation in application protocols.
Calcium hydroxide–dexamethasone paste Combines the intended antimicrobial action of calcium hydroxide with corticosteroid-mediated inflammation control. Optimal formulation, compatibility, dosage, and clinical indications remain uncertain.
Corticosteroid–antibiotic paste Combines anti-inflammatory activity with antimicrobial activity, depending on the ingredients. Antibiotic-specific risks, potential discoloration, allergies, and antimicrobial stewardship concerns.

Clinical note: Ledermix is a corticosteroid–antibiotic paste containing triamcinolone acetonide and demeclocycline, not dexamethasone. Evidence for one formulation should not be extrapolated directly to another.


✅ What Does the Clinical Evidence Show?
A randomized clinical trial by Ghanbarzadegan et al. (2019) evaluated intracanal medicaments in 90 necrotic molars and premolars. The investigators compared calcium hydroxide mixed with saline, calcium hydroxide mixed with 2% chlorhexidine, and calcium hydroxide mixed with dexamethasone.
The calcium hydroxide–dexamethasone group demonstrated lower pain scores than the calcium hydroxide–saline group during the first 24–72 hours. Differences were no longer statistically significant at 96 hours. These findings suggest a possible short-term analgesic benefit, but they do not establish universal superiority or define an optimal formulation.
A separate randomized trial published in 2024 investigated dexamethasone as a final intracanal rinse in patients with symptomatic irreversible pulpitis. The investigators reported better postoperative pain relief than with saline. However, this study evaluated a rinse, not a paste, and its findings should not be treated as direct evidence for sustained intracanal medication.
The broader evidence remains limited by differences in study design, patient selection, formulations, and outcome measurements. Intracanal dexamethasone is promising, but the evidence is insufficient to support routine use in every root canal treatment.

📌 Recommended Article :
Dental Article🔽 CTZ Paste in Primary Teeth Pulp Therapy: Indications, Benefits and Clinical Protocol ... The use of CTZ paste (Chloramphenicol–Tetracycline–Zinc Oxide) in primary teeth remains a topic of interest, especially in cases of infected primary molars where traditional pulpectomy is not feasible.
✅ Safety and Clinical Limitations
Local administration does not eliminate the possibility of adverse effects. Relevant considerations include:

▪️ Potential local immunomodulation and effects on tissue healing.
▪️ Possible systemic exposure, depending on the preparation and amount used.
▪️ Formulation compatibility, stability, and removability.
▪️ The risk of suppressing inflammatory symptoms without adequately controlling infection.

When antibiotics are included in a paste, clinicians must also consider allergies, antimicrobial stewardship, and formulation-specific adverse effects.
Calcium hydroxide remains an established intracanal medicament when an interappointment dressing is indicated. Adding dexamethasone should not be assumed to improve disinfection or long-term healing without stronger comparative evidence.

📌 Recommended Article :
Dental Article🔽 Webinar: Behavior management in pediatric dentistry - Dr. Eyal Simchi ... Communication with parents and the pediatric patient is important. The dentist must transmit security and empathy, with the intention of reducing parental anxiety.
💬 Discussion
The clinical interest in intracanal dexamethasone reflects an important distinction in endodontic pharmacology: controlling inflammation is not the same as controlling infection. A corticosteroid may reduce inflammatory symptoms, while successful treatment still depends on adequate microbial control and an effective coronal seal.
Combining dexamethasone with calcium hydroxide is scientifically interesting because the components have different intended functions. Nevertheless, the clinical performance of a combination depends on its formulation, concentration, chemical compatibility, and biological effects. Evidence from a small number of clinical trials cannot establish the safety or effectiveness of all compounded preparations.
The 2024 expert consensus on irrigation and intracanal medication emphasizes that intracanal medicaments are adjuncts to, rather than replacements for, thorough preparation and irrigation. Further randomized clinical trials should evaluate standardized formulations, adverse effects, postoperative pain, and long-term periapical healing.

✍️ Conclusion
Intracanal dexamethasone represents a potential adjunct for managing inflammation and postoperative pain in endodontics. Preliminary clinical evidence supports further investigation of calcium hydroxide–dexamethasone combinations and local corticosteroid application.
However, differences between solutions, compounded pastes, and commercially available corticosteroid–antibiotic preparations must be respected. Until stronger evidence establishes standardized protocols and long-term outcomes, intracanal dexamethasone should be regarded as a promising but insufficiently validated approach rather than a routine replacement for established endodontic medicaments.

🎯 Clinical Recommendations
▪️ Consider intracanal corticosteroid evidence critically and distinguish findings for dexamethasone from those for other glucocorticoids.
▪️ Do not assume that adding dexamethasone to calcium hydroxide improves antimicrobial efficacy or long-term healing.
▪️ Avoid unvalidated compounded formulations when compatibility, stability, dosage, and tissue safety have not been established.
▪️ Prioritize definitive infection control, appropriate case selection, and a durable coronal seal.

📚 References
✔ Ghanbarzadegan, A., Ajami, M., & Aminsobhani, M. (2019). The effect of different combinations of calcium hydroxide as intra-canal medicament on endodontic pain: A randomized clinical trial study. Iranian Endodontic Journal, 14(1), 1–6. https://doi.org/10.22037/iej.v14i1.22815
✔ Moskow, A., Morse, D. R., Krasner, P., & Furst, M. L. (1984). Intracanal use of a corticosteroid solution as an endodontic anodyne. Oral Surgery, Oral Medicine, and Oral Pathology, 58(5), 600–604. https://doi.org/10.1016/0030-4220(84)90086-0
✔ Negm, M. M. (2001). Intracanal use of a corticosteroid-antibiotic compound for the management of posttreatment endodontic pain. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 92(4), 435–439. https://doi.org/10.1067/moe.2001.115975
✔ Zou, X., Zheng, X., Liang, Y., Zhang, C., Fan, B., Liang, J., Ling, J., Bian, Z., Yu, Q., Hou, B., Chen, Z., Wei, X., Qiu, L., Chen, W., He, W., Xu, X., Meng, L., Chen, Z., Chen, L., ... Yue, L. (2024). Expert consensus on irrigation and intracanal medication in root canal therapy. International Journal of Oral Science, 16, Article 23. https://doi.org/10.1038/s41368-024-00280-5

📌 More Recommended Items

► Dexamethasone Dental Pain Protocols: Modern Guide
► Pulpectomy in Primary Teeth: Best Filling Materials (ZOE, Vitapex, and Metapex)
► Management of Pulpal Infections in Primary Teeth: Evidence-Based Protocols

martes, 13 de octubre de 2026

Pulpal Emergencies: Clinical and Pharmacological Management

Pulpal Emergencies

Pulpal emergencies require prompt diagnosis, effective pain control, and definitive dental treatment. Common presentations include reversible pulpitis, symptomatic irreversible pulpitis, pulp necrosis, and associated apical inflammation or abscess.

📌 Recommended Article :
Dental Article 🔽 Why Hydrogen Peroxide Should Not Be Used in Modern Endodontic Treatment: Evidence-Based Clinical Justification ... Hydrogen peroxide (H₂O₂) was widely used for decades in root canal therapy due to its effervescence and perceived cleaning capability. However, current endodontic literature strongly discourages its use.
Pharmacological management is primarily intended to provide temporary pain relief and control spreading infection when indicated.

Advertisement

According to the American Dental Association (ADA), nonsteroidal anti-inflammatory drugs (NSAIDs), alone or combined with acetaminophen, are first-line options for temporary management of acute dental pain. Medication does not replace definitive treatment, such as pulpotomy, pulpectomy, root canal treatment, or extraction when indicated.

✅ Clinical assessment and initial management

▪️ History: Assess pain onset, duration, spontaneous or nocturnal pain, thermal sensitivity, swelling, fever, allergies, current medications, and relevant medical conditions.
▪️ Examination: Perform pulp sensibility tests, percussion, palpation, periodontal assessment, and appropriate radiographic evaluation.
▪️ Diagnosis: Differentiate reversible pulpitis, symptomatic irreversible pulpitis, pulp necrosis, symptomatic apical periodontitis, and acute apical abscess.
▪️ Emergency intervention: Prioritize appropriate local anesthesia and definitive treatment. Drainage is indicated when an accessible abscess requires it.

Facial swelling that progresses rapidly, difficulty swallowing or breathing, floor-of-mouth swelling, or systemic toxicity requires urgent hospital evaluation because of the risk of deep-space infection or airway compromise.

📌 Recommended Article :
Dental Article 🔽 Management of Pulpal Infections in Primary Teeth: Evidence-Based Protocols ... The 2024 American Academy of Pediatric Dentistry (AAPD) guidelines emphasize accurate diagnosis, conservative pulp therapy, and the use of bioactive materials such as MTA and Biodentine for improved long-term success
✅ Pharmacological management: adult doses
The following regimens are reference options for immunocompetent adults requiring temporary pain control. Selection must account for medical history, contraindications, concomitant medications, and local prescribing guidance.

Table 1. Analgesics for acute pulpal pain
Medication Adult dose Clinical considerations
Ibuprofen 400 mg every 6 hours as needed First-line NSAID; avoid in active peptic ulcer, significant renal disease, or relevant NSAID hypersensitivity.
Naproxen sodium 440 mg initially, then 220 mg every 8–12 hours as needed Alternative NSAID; consider gastrointestinal, renal, and cardiovascular risks.
Acetaminophen (paracetamol) 500–1,000 mg every 6–8 hours as needed Alternative when NSAIDs are unsuitable; reduce or avoid as appropriate in liver disease and account for all combination products.
Ibuprofen + acetaminophen Ibuprofen 400 mg + acetaminophen 500 mg per dose Combination may improve analgesia when both medications are appropriate.
Dosing safety: Use the lowest effective dose for the shortest necessary period. Do not combine ibuprofen with naproxen or another NSAID. The ADA guideline lists maximum daily doses of 2,400 mg for ibuprofen, 1,100 mg for naproxen sodium, and 4,000 mg for acetaminophen; these are guideline ceilings, not targets. Lower limits may be appropriate, especially for acetaminophen.

Local anesthesia
Local anesthetic administration can provide immediate relief while definitive treatment is arranged or performed. Lidocaine 2% with epinephrine 1:100,000 is a commonly used option. Select the agent and dose according to the patient's medical status, product labeling, weight where relevant, and maximum recommended dose. In cases of severe irreversible pulpitis, supplemental anesthesia may be required.

📌 Recommended Article :
Dental Article 🔽 Pulp Necrosis in Primary Teeth: Diagnosis and Evidence-Based Management ... Pulp necrosis in primary teeth is a common consequence of untreated caries, trauma, or chronic inflammation. Early detection is crucial to prevent infection, pathological root resorption, and damage to the developing permanent successor.
✅ Antibiotics: indications and adult regimens
Antibiotics are not routinely indicated for pulpitis, including symptomatic irreversible pulpitis, even when pain is severe. They do not eliminate the inflamed pulp or replace endodontic treatment.
Systemic antibiotics may be indicated when an odontogenic infection has systemic involvement, such as fever or malaise, or when there is spreading infection. The need for immediate referral or hospital care must be assessed independently of the prescription.

Table 2. Antibiotic options when indicated
Antibiotic Adult regimen Important notes
Amoxicillin 500 mg every 8 hours ADA first-line option when antibiotics are indicated.
Penicillin V potassium 500 mg every 6 hours Alternative first-line option under ADA guidance.
Clindamycin 300 mg orally every 6 hours for 3–7 days, when indicated Use cautiously due to the risk of Clostridioides difficile infection, including potentially life-threatening colitis. Consider safer alternatives when appropriate.
The ADA guideline specifies a 3–7-day course for these regimens when indicated, reassessment within 3 days, and discontinuation 24 hours after symptoms resolve. Confirm allergy history and applicable local guidelines before prescribing. Avoid selecting alternatives such as clindamycin without careful consideration of adverse effects, including Clostridioides difficile infection.

📌 Recommended Article :
Dental Article 🔽 Pulp Polyps in Children: Causes, Diagnosis, and Treatment Options in Pediatric Dentistry ... While it is a protective response to chronic inflammation, it reflects significant pulpal exposure, often requiring endodontic or surgical management.
💬 Discussion
Pharmacological management of pulpal emergencies should be guided by the clinical diagnosis rather than pain intensity alone. The evidence supports NSAIDs, with or without acetaminophen, as first-line temporary analgesia, while routine opioid prescribing is discouraged.
Antibiotic overprescribing remains a relevant concern in endodontic emergencies. In immunocompetent adults, antibiotics offer limited benefit for most conditions confined to the pulp and periapical tissues when definitive dental treatment is available. Treatment delay should therefore be minimized, and patients with systemic involvement or progressive infection require prompt reassessment.

✍️ Conclusion
Effective management of pulpal emergencies depends on accurate diagnosis, appropriate analgesia, and timely definitive dental treatment. Antibiotics should be reserved for appropriate clinical indications, and patients with signs of spreading infection must receive urgent evaluation. A prescription alone is insufficient to resolve the underlying pulpal disease.

🎯 Clinical Recommendations
▪️ Prioritize definitive treatment: Remove the source of pulpal disease through appropriate vital pulp therapy, endodontic treatment, drainage, or extraction.
▪️ Individualize analgesia: Consider medical history, contraindications, drug interactions, and cumulative daily doses before prescribing.
▪️ Avoid unnecessary antibiotics: Severe pulpal pain alone is not an indication for systemic antimicrobial therapy.
▪️ Establish a clear follow-up plan: Reassess deterioration promptly and ensure definitive treatment is completed without unnecessary delay.

📚 References
✔ Carrasco-Labra, A., Polk, D. E., Urquhart, O., Aghaloo, T., Claytor, J. W., Dhar, V., et al. (2024). Evidence-based clinical practice guideline for the pharmacologic management of acute dental pain in adolescents, adults, and older adults: A report from the American Dental Association Science and Research Institute, the University of Pittsburgh, and the University of Pennsylvania. The Journal of the American Dental Association, 155(2), 102–117.e9. https://doi.org/10.1016/j.adaj.2023.10.009
✔ Lockhart, P. B., Tampi, M. P., Abt, E., Aminoshariae, A., Durkin, M. J., Fouad, A. F., Gopal, P., Hatten, B. W., Kennedy, E., Lang, M. S., Patton, L. L., Paumier, T., Suda, K. J., Pilcher, L., Urquhart, O., O’Brien, K. K., & Carrasco-Labra, A. (2019). Evidence-based clinical practice guideline on antibiotic use for the urgent management of pulpal- and periapical-related dental pain and intra-oral swelling: A report from the American Dental Association. The Journal of the American Dental Association, 150(11), 906–921.e12. https://doi.org/10.1016/j.adaj.2019.08.020
✔ American Association of Endodontists. (n.d.). Emergency treatment. https://www.aae.org/specialty/topic/emergency-treatment/

📌 More Recommended Items

► Why Formocresol Is No Longer Recommended in Pediatric Pulp Therapy: Evidence-Based Risks and Modern Alternatives
► Pulpectomy. Step-by-Step Procedure - Access, Preparation, and Obturation
► Apexogenesis: Step by step procedure

lunes, 28 de septiembre de 2026

Regenerative Pulp Therapy in Pediatric Dentistry: When Is It Truly Indicated?

Regenerative Pulp Therapy

Regenerative pulp therapy is increasingly discussed in pediatric dentistry, but its clinical indication is narrower than the term may suggest.

📌 Recommended Article :
Dental Article 🔽 Management of Pulpal Infections in Primary Teeth: Evidence-Based Protocols ... The 2024 American Academy of Pediatric Dentistry (AAPD) guidelines emphasize accurate diagnosis, conservative pulp therapy, and the use of bioactive materials such as MTA and Biodentine for improved long-term success.
In current clinical practice, regenerative endodontic procedures (REPs) are primarily considered for immature permanent teeth with pulp necrosis, particularly when continued root development would provide a biological advantage.

Advertisement

This distinction is important because regenerative endodontics should not be confused with vital pulp therapy, such as indirect pulp treatment or pulpotomy.
In a vital immature permanent tooth, preservation of the existing pulp is generally the preferred biological strategy; regeneration is primarily considered when the pulp is already necrotic and conventional treatment would leave a tooth with thin dentinal walls and an open apex.
The current AAPD guidance specifically identifies regenerative endodontics as an option for immature permanent teeth with necrotic pulp and apical periodontitis.

📌 Recommended Article :
Dental Article 🔽 Pulp Exposure in Children: Emergency Treatment Guide ... The appropriate emergency treatment depends primarily on the pulpal diagnosis, extent and cause of exposure, ability to achieve hemostasis, tooth restorability, root development, and presence of infection.
✅ What Is Regenerative Endodontic Therapy?
Regenerative endodontic procedures (REPs) are biologically based treatments designed to disinfect the canal while creating conditions that may permit tissue ingrowth and continued development of an immature permanent root.

Unlike conventional root canal treatment, which removes the infected pulp and obturates the canal, REPs aim to preserve the potential for:
▪️ Continued root lengthening ▪️ Thickening of dentinal walls ▪️ Apical maturation ▪️ Resolution of periapical inflammation or apical periodontitis

Importantly, radiographic evidence of continued root development does not necessarily demonstrate regeneration of a normal pulp-dentin complex. Current literature emphasizes that clinical success and tooth survival are more predictable than true pulp regeneration or recovery of normal pulp function.

📌 Recommended Article :
Dental Article 🔽 Pediatric Pulpectomy Errors and Prevention Guide ... Understanding the most frequent clinical errors and implementing preventive strategies are essential for optimizing therapeutic success and maintaining arch integrity during child development.
✅ When Is Regenerative Therapy Actually Indicated?
The strongest clinical indication is an immature permanent tooth with necrotic pulp and an open apex, especially when the tooth is restorable and preservation of further root development is desirable.

Typical candidates include:
▪️ Immature permanent tooth
▪️ Necrotic pulp
▪️ Open or incompletely developed apex
▪️ Apical periodontitis or a periapical lesion may be present
▪️ Adequate tooth structure for restoration
▪️ A patient and family able to comply with follow-up
▪️ No contraindication to the required intracanal medicaments

The AAE's clinical considerations similarly identify a necrotic immature permanent tooth as the fundamental case-selection criterion and emphasize patient compliance, restorability, and appropriate informed consent.

📌 Recommended Article :
Dental Article 🔽 Pulpectomy in Primary Teeth: Best Filling Materials (ZOE, Vitapex, and Metapex) ... Pulpectomy is a widely accepted endodontic procedure for infected or necrotic primary teeth, aiming to preserve the tooth until its natural exfoliation.
✅ Clinical Indication: At a Glance

Clinical Indications for Regenerative Endodontic Procedures

Clinical Factor Typical Finding Clinical Significance
Tooth type Immature permanent tooth Root development remains incomplete.
Pulp status Necrotic pulp Vital pulp therapy is no longer the appropriate biological objective.
Apical development Open or immature apex Provides access to the apical tissues involved in the regenerative process.
Periapical status Apical periodontitis may be present Periapical disease does not automatically exclude regenerative treatment.
Restorability Adequate remaining tooth structure A durable coronal seal is essential for long-term success.
✅ When Regenerative Therapy Is Not the First Choice
Regenerative endodontics is not a substitute for vital pulp therapy.
For an immature permanent tooth with a vital pulp or reversible pulpitis, preservation of the existing pulp through appropriate vital pulp therapy should generally be considered first. The AAPD includes indirect pulp treatment, direct pulp capping, partial pulpotomy, and complete pulpotomy among the vital pulp therapies applicable to immature permanent teeth.
Similarly, primary teeth are not the principal indication for regenerative endodontic procedures. Current AAPD recommendations address primary teeth using vital pulp therapies when the pulp is vital and pulpectomy or other nonvital approaches when necrosis or irreversible disease is present.

Therefore, the following situations should prompt consideration of another treatment strategy:
Clinical Situation More Appropriate Approach
Vital immature permanent tooth Vital pulp therapy
Reversible pulpitis Vital pulp therapy
Necrotic mature permanent tooth Conventional endodontic treatment is generally established
Necrotic immature permanent tooth with open apex Regenerative endodontic procedure may be considered
Non-restorable tooth Extraction or other appropriate treatment
✅ Biological Rationale
The principal advantage of regenerative treatment in the immature permanent tooth is not simply elimination of infection. It is the possibility of preserving or enhancing root development after pulpal necrosis.
A conventional apexification procedure can establish an apical barrier and facilitate canal obturation, but it does not reliably reproduce continued physiological root maturation. REPs, in contrast, are intended to create an environment that can support continued deposition of hard tissue along the canal walls and further root development.
This distinction is particularly relevant in young permanent teeth because thin dentinal walls increase susceptibility to cervical or root fracture. Consequently, maintaining or increasing root wall thickness may have important long-term biological implications.

📌 Recommended Article :
Dental Article 🔽 Pulpotomy vs. Pulpectomy in Primary Teeth: A Contemporary Clinical Guide ... Understanding the clinical indications, long-term outcomes, advantages, and limitations of each technique is essential for optimizing patient care and maintaining primary teeth until exfoliation.
✅ Key Clinical Considerations
A regenerative procedure is highly dependent on case selection, infection control, and coronal sealing.
The contemporary AAE protocol emphasizes conservative canal disinfection, avoidance of unnecessary mechanical instrumentation of fragile immature roots, and careful control of irrigant extrusion. Calcium hydroxide or an appropriately prepared antibiotic formulation may be used as an intracanal medicament, followed by induction of intracanal bleeding or another scaffold strategy according to the selected protocol.
However, protocols continue to evolve. A 2024 systematic review and network meta-analysis found favorable clinical and radiographic outcomes with several scaffold approaches, but the certainty of evidence varied from low to very low, particularly for comparisons among different regenerative scaffolds.
Recent evidence also supports caution when interpreting radiographic "regeneration." A 2026 systematic review found high pooled clinical success and tooth survival across different degrees of root maturity, while complete apical closure and recovery of pulp vitality were considerably more variable. The authors specifically emphasized that clinical success does not necessarily demonstrate true pulp-dentin regeneration.

📌 Recommended Article :
Dental Article 🔽 Pulp Exposure in Children: Emergency Treatment Guide ... The appropriate emergency treatment depends primarily on the pulpal diagnosis, extent and cause of exposure, ability to achieve hemostasis, tooth restorability, root development, and presence of infection.
💬 Discussion
The most important clinical question is not whether regenerative endodontics is possible, but whether it provides a meaningful biological advantage for the specific tooth.
For a necrotic immature permanent tooth, regenerative therapy can be attractive because conventional treatment may leave a tooth with compromised root dimensions. Evidence from systematic reviews indicates that REPs can produce high rates of clinical healing and tooth survival, while also providing greater potential for root lengthening and dentinal wall thickening than procedures designed solely to create an apical barrier.
Nevertheless, the evidence does not justify interpreting every increase in root dimensions as genuine regeneration of functional pulp tissue. Furthermore, treatment protocols remain heterogeneous, long-term randomized evidence is limited, and complications such as crown discoloration can occur, particularly with some antibiotic-based protocols.
Thus, regenerative endodontics should be regarded as a selective biological treatment for appropriately chosen immature permanent teeth, rather than a routine alternative to vital pulp therapy or conventional root canal treatment.

🎯 Clinical Recommendations
▪️ Confirm pulpal and periapical diagnosis carefully before considering a regenerative procedure; case selection is more important than the regenerative protocol itself.
▪️ Prioritize vital pulp therapy when the pulp remains viable, particularly in an immature permanent tooth where apexogenesis can still occur.
▪️ Consider REP primarily when there is a necrotic immature permanent tooth with an open apex and preservation of further root development is clinically desirable.
▪️ Establish effective infection control and a durable coronal seal; these remain fundamental determinants of treatment success.
▪️ Discuss with parents and patients that the objective includes healing and continued root development, not a guaranteed recreation of a normal pulp-dentin complex.
▪️ Maintain long-term clinical and radiographic follow-up, because radiographic maturation and pulp sensibility responses can be variable.

✍️ Conclusion
Regenerative endodontic procedures have their clearest role in immature permanent teeth with pulp necrosis and an open apex. Their principal biological rationale is the possibility of continued root maturation and reinforcement of thin dentinal walls.
They should not replace vital pulp therapy when a healthy or reparable pulp remains, nor should they be routinely extrapolated to primary teeth. Current evidence supports favorable healing and survival outcomes, but the terminology of "regeneration" should be interpreted cautiously because true functional pulp regeneration remains less predictable than clinical resolution and radiographic root development.

📚 References

✔ American Academy of Pediatric Dentistry. (2025). Pulp therapy for primary and immature permanent teeth: Indications and objectives. In The Reference Manual of Pediatric Dentistry (pp. 487–496). American Academy of Pediatric Dentistry.
✔ American Association of Endodontists. (2022). AAE clinical considerations for a regenerative procedure: Revised November 2022. American Association of Endodontists.
✔ Coll, J. A., Dhar, V., Chen, C.-Y., Crystal, Y. O., Guelmann, M., Marghalani, A. A., AlShamali, S., Xu, Z., Glickman, G. N., & Wedeward, R. (2024). Use of vital pulp therapies in primary teeth 2024. Pediatric Dentistry, 46(1), 13–26.
✔ Galler, K. M., Krastl, G., Simon, S., Van Gorp, G., Meschi, N., Vahedi, B., & Lambrechts, P. (2016). European Society of Endodontology position statement: Revitalization procedures. International Endodontic Journal, 49(8), 717–723. https://doi.org/10.1111/iej.12629
✔ Sabeti, M., Ghobrial, D., Zanjir, M., da Costa, B. R., Young, Y., & Azarpazhooh, A. (2024). Treatment outcomes of regenerative endodontic therapy in immature permanent teeth with pulpal necrosis: A systematic review and network meta-analysis. International Endodontic Journal, 57(3), 238–255. https://doi.org/10.1111/iej.13999
✔ Tewari, N., Devi, P., Sampath, S., Mathur, V. P., Tsilingaridis, G., Wikström, A., Rahul, M., & Bansal, K. (2025). Comparative effectiveness of regenerative endodontic treatment versus apexification for necrotic immature permanent teeth with or without apical periodontitis: An umbrella review. Endodontic Therapy, 41(3), 263–282. https://doi.org/10.1111/edt.13028

📌 More Recommended Items

► Zinc Oxide Eugenol vs Calcium Hydroxide–Iodoform in Pulpectomy
► Why Formocresol Is No Longer Recommended in Pediatric Pulp Therapy: Evidence-Based Risks and Modern Alternatives
► Why Hydrogen Peroxide Should Not Be Used in Modern Endodontic Treatment: Evidence-Based Clinical Justification

jueves, 10 de septiembre de 2026

Minimally Invasive Pulpotomy in Symptomatic Teeth: Is It Possible?

Minimally Invasive Pulpotomy

Vital pulp therapy (VPT) has undergone a significant change in recent years. Historically, teeth with symptoms traditionally diagnosed as irreversible pulpitis were generally treated with root canal treatment or extraction.

📌 Recommended Article :
Dental Article 🔽 Partial pulpotomy vs. Conventional (full) pulpotomy in primary teeth — a comparative, evidence-based review ... This article compares partial pulpotomy and conventional (full/coronal) pulpotomy in primary teeth, focusing on definitions, technique differences, materials, clinical outcomes, and benefits.
Current evidence indicates that selected mature permanent teeth with symptomatic pulpitis may retain sufficient reparative potential to be managed with pulpotomy.

Advertisement

However, minimally invasive pulpotomy should not be regarded as a single standardized technique. The term is better understood as a tissue-preserving therapeutic approach in which the amount of pulp removed is limited to the tissue considered clinically compromised, while maintaining the vitality of the remaining pulp.
This distinction is important because Cvek partial pulpotomy represents a specific historical technique for partial removal of exposed coronal pulp, particularly in traumatic pulp exposures, whereas contemporary pulpotomy protocols have expanded into the management of cariously exposed mature permanent teeth with symptoms indicative of irreversible pulpitis.

📌 Recommended Article :
Dental Article 🔽 Medications Used in Pulpotomies: Properties, Drawbacks, and Brand Names ... Selecting the right medication is crucial for clinical success. Below is an overview of the most commonly used pulpotomy agents, their properties, drawbacks, and commercial names.
✅ What Is Minimally Invasive Pulpotomy?
A minimally invasive approach to pulpotomy aims to preserve the maximum amount of viable pulp compatible with effective removal of inflamed tissue and achievement of hemostasis.
The amount of tissue removed is therefore not determined exclusively by a predefined depth. Instead, it may be adjusted according to the clinical condition of the pulp after exposure.
Three concepts should be distinguished:
Procedure Main Characteristic Typical Clinical Context
Cvek partial pulpotomy Limited removal of superficial exposed pulp, historically involving approximately 1–2 mm of tissue. Traumatic pulp exposure, particularly in permanent incisors.
Contemporary partial pulpotomy Removal of a limited amount of coronal pulp according to tissue condition and the ability to achieve hemostasis. Selected carious pulp exposures, including mature teeth with symptomatic pulpitis.
Full pulpotomy Removal of the entire coronal pulp to the level of the canal orifices while preserving the radicular pulp. Mature teeth in which more extensive coronal pulp removal is required.
The Cvek technique should therefore not be used synonymously with minimally invasive pulpotomy. Its historical evidence base is primarily associated with traumatic pulp exposures, whereas contemporary partial pulpotomy has been investigated in mature permanent teeth with carious exposure and symptomatic pulpitis.

✅ Can Symptomatic Teeth Be Treated With a Minimally Invasive Approach?
Yes, in selected cases.
The current evidence challenges the assumption that symptoms traditionally associated with irreversible pulpitis automatically indicate complete loss of pulpal healing potential. The AAE recognizes that VPT may be considered in appropriately selected mature teeth previously diagnosed with irreversible pulpitis and emphasizes direct assessment of the exposed pulp as an important component of case selection.
A 2024 systematic review and meta-analysis found favorable outcomes for pulpotomy in mature permanent teeth diagnosed with irreversible pulpitis, although the authors emphasized limitations in the available evidence and heterogeneity among studies.
Importantly, the evidence does not mean that every symptomatic tooth is a candidate for partial pulpotomy. Rather, pulpal status must be reassessed after exposure and tissue removal.

📌 Recommended Article :
PDF 🔽 What is the best pulp dressing for pulpotomies in primary teeth? - Review ... Different pulp dressings have been used in pulpotomies, each with different characteristics and properties. The article we share compares all pulp dressings to determine which is the most effective.
✅ Partial Pulpotomy in Symptomatic Mature Teeth
Contemporary randomized clinical trials provide increasing evidence supporting partial pulpotomy in selected mature permanent teeth with symptoms indicative of irreversible pulpitis.
In a randomized trial involving 50 mature molars, partial pulpotomy using Biodentine achieved an 88% success rate at 12 months, compared with 91.6% for full pulpotomy, with no statistically significant difference between groups.
Another randomized trial involving 106 mature mandibular molars reported 80.8% success for partial pulpotomy and 89.8% for complete pulpotomy at 12 months. Although the numerical difference favored complete pulpotomy, it was not statistically significant. The authors concluded that partial pulpotomy may be attempted because of its more conservative nature.
More recent research has also investigated how much pulp should be removed during partial pulpotomy. A 2025 randomized clinical trial compared restricted partial pulpotomy, in which approximately 2–3 mm of superficial pulp was removed only at the exposure site, with an extended approach involving removal of 2–3 mm of superficial pulp throughout the pulp chamber. This reflects the continuing shift toward determining the extent of tissue removal according to biological rather than purely mechanical criteria.

📌 Recommended Article :
Dental Article 🔽 Complete Guide to Pulp Therapy in Primary Teeth: Materials, Techniques, and Success Rates ... Pulp therapy in primary teeth is a cornerstone of pediatric dentistry, aiming to maintain tooth vitality, prevent infection, and preserve arch space until natural exfoliation.
✅ Clinical Determinants of Success
The key issue is not simply how little pulp can be removed, but whether the remaining pulp is capable of healing.
Clinical Factor Importance in Treatment Selection
Preoperative diagnosis Establishes the initial pulpal and periapical diagnosis but cannot determine the exact histological extent of inflammation.
Direct pulp assessment Provides additional information after pulp exposure and removal of clinically compromised tissue.
Hemostasis Controlled bleeding after pulp amputation supports proceeding with vital pulp therapy; persistent bleeding requires reassessment.
Aseptic isolation Reduces microbial contamination of the exposed pulp and treatment field.
Extent of inflammation Helps determine whether a limited partial pulpotomy or more extensive coronal pulp removal is appropriate.
Biomaterial Calcium silicate-based hydraulic cements are widely used in contemporary vital pulp therapy.
Coronal seal An effective definitive restoration is essential to prevent bacterial leakage and protect the treated pulp.
In randomized clinical studies, inability to control bleeding within a predefined period has been used as a criterion for abandoning the planned pulpotomy protocol. For example, one trial required hemostasis within six minutes before proceeding with treatment.
However, hemostasis time should not be interpreted as an absolute biological threshold. It is a clinical decision aid rather than a direct histological measurement of pulpal inflammation.

📌 Recommended Article :
Dental Article 🔽 Best Materials for Pulpotomy in Primary Teeth: MTA vs. Biodentine vs. Ferric Sulfate ... Modern evidence supports the use of bioceramic materials due to their biocompatibility and predictable healing, while traditional agents such as ferric sulfate remain in use for their cost-effectiveness.
✅ A Contemporary Minimally Invasive Protocol
A tissue-preserving approach should follow a biologically guided sequence:

1. Establish the pulpal and periapical diagnosis.
2. Obtain appropriate preoperative radiographs.
3. Achieve rubber dam isolation and aseptic control.
4. Remove infected dentin and expose the pulp when indicated.
5. Remove the clinically compromised coronal pulp.
6. Assess the remaining tissue and establish hemostasis.
7. Determine whether partial or full pulpotomy provides the most appropriate level of tissue removal.
8. Apply an appropriate calcium silicate-based biomaterial.
9. Provide a durable definitive coronal restoration.
10. Perform clinical and radiographic follow-up.
This approach is consistent with the contemporary VPT concept that direct visualization of pulp tissue after exposure can contribute to treatment selection, because conventional sensibility testing cannot establish the histological status of the pulp with sufficient precision.

📌 Recommended Article :
Dental Article 🔽 Pulpotomy vs. Pulpectomy in Primary Teeth: A Contemporary Clinical Guide ... Understanding the clinical indications, long-term outcomes, advantages, and limitations of each technique is essential for optimizing patient care and maintaining primary teeth until exfoliation.
✅ Is the Cvek Technique the Same Procedure?
No.
The Cvek partial pulpotomy is a specific form of partial pulpotomy historically associated with traumatic crown fractures and exposed vital pulp, particularly in permanent incisors. The classic procedure involved removal of a small superficial portion of exposed pulp followed by placement of a pulp-capping material.
Long-term clinical studies have demonstrated favorable outcomes for partial pulpotomy in traumatized permanent incisors.
Contemporary partial pulpotomy for symptomatic carious teeth is conceptually related because both procedures preserve vital pulp tissue. However, they should not be treated as identical techniques because their indications, clinical circumstances, and evidence bases differ.

Thus:
Cvek partial pulpotomy = a specific partial pulpotomy technique.
Minimally invasive pulpotomy = a broader tissue-preservation approach that may involve partial or, when clinically necessary, full pulpotomy.

📌 Recommended Article :
Webinar 🔽 Webinar: Mastering Primary Teeth Pulpotomies: Techniques and Best Practices for Dental Professionals ... It covers indirect and direct pulp treatment approaches, along with coronal pulpotomy, offering clinicians evidence-based options for managing deep carious lesions while preserving tooth vitality.
💬 Discussion
The most important change in contemporary VPT is not the introduction of a new pulpotomy technique, but the recognition that pulpal inflammation is biologically heterogeneous. Clinical symptoms alone cannot reliably determine whether all remaining pulp tissue has lost its capacity for healing.
Consequently, a diagnosis such as symptomatic irreversible pulpitis should not automatically be interpreted as evidence that every portion of the pulp is irreversibly damaged. The AAE and contemporary evidence support combining preoperative diagnosis with direct intraoperative assessment when VPT is being considered.
The evidence supporting partial pulpotomy is particularly relevant to the minimally invasive concept. Randomized trials have demonstrated favorable short-term outcomes and, in several studies, no statistically significant difference between partial and full pulpotomy.
Nevertheless, the current evidence does not justify assuming that partial pulpotomy is universally superior. Some studies report numerically higher success with full pulpotomy, while follow-up periods remain relatively short in much of the literature. A 2024 meta-analysis likewise concluded that the evidence is promising but affected by heterogeneity and methodological limitations.
Therefore, the objective of minimally invasive pulpotomy should not be “remove as little pulp as possible”. The biologically appropriate objective is to remove compromised tissue while preserving the greatest amount of healthy, functional pulp that can predictably remain viable.

✍️ Conclusion
Minimally invasive pulpotomy is a valid contemporary concept within vital pulp therapy, but it is not synonymous with the Cvek technique.
The Cvek procedure is a specific form of partial pulpotomy historically used for traumatic pulp exposures. Contemporary minimally invasive pulpotomy encompasses a broader tissue-preserving philosophy that may involve partial or full pulpotomy according to the clinical condition of the pulp.
In selected mature permanent teeth with symptoms indicative of irreversible pulpitis, current evidence supports pulpotomy as a potential alternative to root canal treatment. However, successful treatment depends on appropriate case selection, asepsis, direct pulp assessment, effective hemostasis, suitable biomaterials, and a reliable coronal seal.

🎯 Clinical Recommendations
▪️ Do not use Cvek partial pulpotomy and minimally invasive pulpotomy as interchangeable terms.
▪️ Consider contemporary partial pulpotomy in selected symptomatic mature teeth when the remaining pulp demonstrates favorable clinical characteristics after tissue removal.
▪️ Do not impose a predetermined depth of tissue removal when the clinical condition of the pulp indicates that additional removal is necessary.
▪️ Use hemostasis and direct pulp assessment as important intraoperative decision points rather than relying exclusively on the preoperative diagnosis.
▪️ If a limited partial pulpotomy does not provide a suitable pulpal wound or controlled hemostasis, progress to a more extensive pulpotomy or reconsider VPT, according to the clinical circumstances.
▪️ Consider long-term follow-up essential because short-term symptom resolution does not by itself demonstrate sustained pulp vitality.

📚 References

✔ American Association of Endodontists. (2021). AAE position statement on vital pulp therapy. American Association of Endodontists.
✔ Duncan, H. F., Kirkevang, L.-L., Peters, O. A., El-Karim, I., Krastl, G., Del Fabbro, M., Chong, B. S., Galler, K. M., Segura-Egea, J. J., & Kebschull, M. (2023). Treatment of pulpal and apical disease: The European Society of Endodontology S3-level clinical practice guideline. International Endodontic Journal, 56(Suppl. 3), 238–295. https://doi.org/10.1111/iej.13974
✔ Jassal, A., Nawal, R. R., Yadav, S., Talwar, S., Yadav, S., & Duncan, H. F. (2023). Outcome of partial and full pulpotomy in cariously exposed mature molars with symptoms indicative of irreversible pulpitis: A randomized controlled trial. International Endodontic Journal, 56(3), 331–344. https://doi.org/10.1111/iej.13872
✔ Li, Y., Wang, W., Zeng, Q., Tang, M., Massey, J., Bergeron, B. E., Gu, L., & Tay, F. R. (2024). Efficacy of pulpotomy in managing irreversible pulpitis in mature permanent teeth: A systematic review and meta-analysis. Journal of Dentistry, 144, 104923. https://doi.org/10.1016/j.jdent.2024.104923
✔ Ramani, A., Sangwan, P., Tewari, S., Duhan, J., Mittal, S., & Kumar, V. (2022). Comparative evaluation of complete and partial pulpotomy in mature permanent teeth with symptomatic irreversible pulpitis: A randomized clinical trial. International Endodontic Journal, 55(5), 430–440. https://doi.org/10.1111/iej.13714
✔ Ramani, A., Sangwan, P., Tewari, S., Duhan, J., Mittal, S., & Kumar, V. (2025). Effect of lateral extent of pulp tissue removal on the outcome of partial pulpotomy for managing cariously exposed mature permanent molars with symptomatic irreversible pulpitis: A randomized clinical trial. International Endodontic Journal, 58(1), 71–83. https://doi.org/10.1111/iej.14152
✔ Tzanetakis, G. N., Koletsi, D., & Georgopoulou, M. (2023). Treatment outcome of partial pulpotomy using two different calcium silicate materials in mature permanent teeth with symptoms of irreversible pulpitis: A randomized clinical trial. International Endodontic Journal, 56(10), 1178–1196. https://doi.org/10.1111/iej.13955

📌 More Recommended Items

► Pediatric Pulpectomy Errors and Prevention Guide
► Zinc Oxide Eugenol vs Calcium Hydroxide–Iodoform in Pulpectomy
► Why Is Dental Pain More Intense at Night?